DexCom Balance Sheet
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DexCom financial position
At the end of fiscal 2025, DexCom reported total assets of $6.34 billion, down 2.2% from a year earlier against total liabilities of $3.59 billion. Shareholders' equity stood at $2.75 billion, or 43.3% of assets. The company held $917.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 1.88, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
DexCom balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 917.70M | 606.10M | 566.30M | 642.30M | 1.05B | 817.60M | 446.20M | 1.14B | 441.50M | 94.50M |
| Short-Term Investments | — | 1.73B | 2.16B | 1.81B | 1.36B | — | — | 92.70M | 107.10M | 29.20M |
| Receivables | 1.22B | 1.01B | 973.90M | 713.30M | 514.30M | 428.50M | 286.30M | 226.70M | 134.30M | 101.70M |
| Inventory | 629.10M | 542.60M | 559.60M | 306.70M | 357.30M | 234.70M | 119.80M | 70.70M | 45.20M | 45.40M |
| Total Current Assets | 4.03B | 4.30B | 4.43B | 3.67B | 3.68B | 3.42B | 1.97B | 1.70B | 744.70M | 280.00M |
| Property, Plant & Equipment | 1.56B | 1.34B | 1.11B | 1.06B | 801.80M | 515.30M | 321.30M | 183.10M | 145.60M | 109.40M |
| Goodwill | 24.20M | 22.80M | 25.20M | 25.70M | 26.50M | 19.30M | 18.60M | 18.70M | 12.10M | 11.30M |
| Intangible Assets | 70.80M | 103.40M | 134.50M | 173.30M | 31.50M | — | — | — | — | 200.00K |
| Long-Term Investments | 218.00M | 119.30M | 38.50M | 19.00M | 320.70M | — | — | 14.40M | — | — |
| Total Assets | 6.34B | 6.48B | 6.26B | 5.39B | 4.93B | 4.29B | 2.40B | 1.92B | 904.10M | 402.80M |
| Accounts Payable | 344.30M | 345.30M | 276.40M | 237.90M | 189.40M | 163.30M | 102.30M | 75.50M | 46.70M | 41.10M |
| Total Current Liabilities | 2.14B | 2.93B | 1.56B | 1.84B | 720.80M | 614.10M | 360.20M | 222.40M | 138.90M | 102.40M |
| Total Liabilities | 3.59B | 4.38B | 4.20B | 3.26B | 2.89B | 2.46B | 1.51B | 1.25B | 484.70M | 119.00M |
| Shareholders' Equity | 2.75B | 2.10B | 2.07B | 2.13B | 2.04B | 1.55B | 882.60M | 663.30M | 419.40M | 283.80M |
| Retained Earnings | 2.43B | 1.60B | 1.02B | 479.90M | 138.70M | -78.20M | -695.70M | -798.90M | -671.80M | -621.00M |
| Net Cash (Debt) | 917.70M | 2.34B | 2.73B | 2.45B | 2.41B | 817.60M | 446.20M | 1.23B | 548.60M | 123.70M |
| Shares Outstanding | 384.80M | 390.70M | 385.40M | 386.30M | 388.00M | 96.10M | 91.60M | 90.00M | 87.00M | 84.60M |
This table shows 10 annual periods of DexCom's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow DXCM's reporting calendar. What is a balance sheet?